Loading...
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer
Histologic transformation to small cell neuroendocrine prostate cancer occurs in a subset of patients with advanced prostate cancer as a mechanism of treatment resistance. Rovalpituzumab tesirine (SC16LD6.5) is an antibody-drug conjugate that targets delta-like protein 3 (DLL3) and was initially dev...
Na minha lista:
| Udgivet i: | Sci Transl Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6525633/ https://ncbi.nlm.nih.gov/pubmed/30894499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aav0891 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|